MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve the Audited Financial Results of the Company (both Standalone and Consolidated) for the Quarter and Year ended 31st March 2023. The Board of Directors will also consider recommendation of dividend if any for the Financial Year 2022-23.